CytoSorbents secure FDA breakthrough designation for CytoSorb technology
CytoSorbents, a critical care immunotherapy company, has secured the USFood and Drug Administration (FDA) breakthrough designation for its CytoSorb technology. CytoSorb is designed for the removal of ticagrelor